Abstracts tagged "Sjogren’s syndrome and ultrasonography"

Abstract Number: 1575 • 2018 ACR/ARHP Annual Meeting
The Association between Salivary Gland Ultrasonography and Clinical Manifestation in Patients with Early Primary Sjögren’s Syndrome
Yen-Fu Chen¹ and Yao-Fan Fang², ¹Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, ²Chang-Gung Memorial Hospital, Taoyuan city, Taiwan
Background/Purpose: To investigate the clinical manifestations in patients with early primary Sjögren¡¦s syndrome based on different severity score under salivary gland ultrasonography.Methods: We enrolled 44…
Abstract Number: 1488 • 2017 ACR/ARHP Annual Meeting
Correlation between Lung Ultrasound, HRCT Findings and Pulmonary Function Tests in Primary Sjögren’s Syndrome (pSS)-Associated Interstitial Lung Disease
Francesco Ferro¹, Alessandra Bulleri², Andrea Delle Sedie¹, Simone Barsotti¹, Nicoletta Luciano¹, Elisa Cioffi³, Elena Elefante¹, Gianfranco Puppo⁴, Marta Mosca¹ and Chiara Baldini⁵, ¹Rheumatology Unit, University of Pisa, Pisa, Italy, ²Radiology Unit, University of Pisa, Pisa, Italy, ³Rheumatology Unit, Rheumatology Unit, University of Pisa, Pisa, Italy, ⁴Pneumology Unit, University of Pisa, Pisa, Italy, ⁵Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy
Background/Purpose: Recently, pleural irregularity (PI), a new lung ultrasound (US) sign, has been proposed as an emerging tool for the diagnosis of interstitial lung disease…
Abstract Number: 2931 • 2014 ACR/ARHP Annual Meeting
Longitudinal Examination with Salivary Gland Ultrasonography (SGUS) of Patients with Primary Sjogren’s Syndrome: A Single Center Experience
Chiara Baldini¹, Nicoletta Luciano¹, Francesca Sernissi¹, Daniela Martini¹, Francesco Ferro¹, Marta Mosca² and Stefano Bombardieri², ¹University of Pisa, Rheumatology Unit, Pisa, Italy, ²Rheumatology Unit, University of Pisa, Pisa, Italy
Background/Purpose: Recently, convincing data have been published on the diagnostic value of salivary gland ultrasonography (SGUS) in primary Sjögren’s syndrome (pSS). However, a limited number…
Abstract Number: 148 • 2014 ACR/ARHP Annual Meeting
Value of Ultrasonography Parotid Glands in Patients with Suspected Primary Sjögren’s Syndrome
Marina Oliver¹, Lida Santiago², Paula Gonzalez¹, Diego Vila¹, Sebastian fernandez Nacul¹, Santiago Scarafia³, Marta Mamani⁴ and Anastasia Secco³, ¹Rheumatology, Rivadavia Hospital, Buenos Aires, Argentina, ²hospital rivadavia, CABA, Argentina, ³Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ⁴Hospital Rivadavia, Capital Federal, Argentina
Background/Purpose Primary Sjogren’s syndrome (pSS) is an autoimmune disorder characterised by chronic lymphocytic infiltration of exocrine tissues. Currently new non-invasive techniques are being continuously introduced…

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.